MiR-21/Smad 7 signaling determines TGF-β1-induced CAF formation

Sci Rep. 2013:3:2038. doi: 10.1038/srep02038.

Abstract

How TGF-β1-mediated signaling pathways are finely tuned to orchestrate the generation of carcinoma-associated fibroblasts (CAFs) is poorly understood. Here, we demonstrate that miR-21 and the signaling of its target Smad 7 determine TGF-β1-induced CAF formation. In primary cultured fibroblasts, mature miR-21 increases after TGF-β1 treatment, whereas the Smad 7 protein level decreases. MiR-21 binds to the 3' UTR of Smad7 mRNA and inhibits its translation, rather than causing its degradation. Most importantly, Smad 7 is bound to Smad 2 and 3, which are thought to competitively bind to TGFBR1, and prevents their activation upon TGF-β1 stimulation. The depletion of miR-21 or the overexpression of Smad 7 blocks TGF-β1-induced CAF formation, whereas the overexpression of miR-21 or the depletion of Smad 7 promotes CAF formation, even without TGF-β1 stimulation. Collectively, these findings clearly demonstrate that miR-21 and Smad7 are critical regulators of TGF-β1 signaling during the induction of CAF formation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Base Pairing
  • Base Sequence
  • Cell Transformation, Neoplastic / drug effects
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism*
  • Fibroblasts / pathology
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Mice
  • MicroRNAs / chemistry
  • MicroRNAs / genetics*
  • MicroRNAs / metabolism
  • Neoplasms / genetics*
  • Neoplasms / metabolism*
  • Neoplasms / pathology
  • Peptide Chain Initiation, Translational
  • Protein Binding
  • RNA Interference
  • Signal Transduction* / drug effects
  • Smad2 Protein / metabolism
  • Smad3 Protein / metabolism
  • Smad7 Protein / chemistry
  • Smad7 Protein / genetics*
  • Smad7 Protein / metabolism
  • Transforming Growth Factor beta1 / administration & dosage
  • Transforming Growth Factor beta1 / metabolism*
  • Transforming Growth Factor beta1 / pharmacology
  • Tumor Burden
  • Tumor Microenvironment
  • Xenograft Model Antitumor Assays

Substances

  • MIRN21 microRNA, human
  • MicroRNAs
  • Smad2 Protein
  • Smad3 Protein
  • Smad7 Protein
  • Transforming Growth Factor beta1